Peijia Medical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-240.00
-432.00
-462.00
-692.00
-2,324.00
-603.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
172.00
-290.00
79.00
16.00
-67.00
-4.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
23.00
-651.00
-440.00
-525.00
-201.00
-115.00
Cash Flow from Investing Activities
-170.00
-426.00
-538.00
-511.00
-18.00
35.00
Cash Flow from Financing Activities
0.00
100.00
139.00
894.00
2,634.00
539.00
Net Cash Inflow / Outflow
-139.00
-965.00
-728.00
-195.00
2,195.00
464.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
6.00
11.00
111.00
-51.00
-219.00
5.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Peijia Medical Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-240.265087722815
-201.480232428748
-39.00
-19.25%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
172.363401138293
-57.8140679538616
229.00
398.13%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
23.000724594888
-235.875065384516
258.00
109.75%
Cash Flow from Investing Activities
-170.404208654888
6.20392882681012
-176.00
-2846.71%
Cash Flow from Financing Activities
0.835936582570885
-120.211150089989
120.00
100.70%
Net Cash Inflow / Outflow
-139.899570846026
-348.9411803524
209.00
59.91%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
6.667976631402
0.941106295293811
6.00
608.53%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 103.53% vs -47.80% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
23.00
-651.40
103.53%






